Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial

ABSTRACT: The study will be conducted in compliance with Good Clinical Practices (ICH-GCP) and the Declaration of Helsinki, and in accordance with applicable legal and regulatory requirements, including archiving of essential documents.

DISEASE(S): Pancreatic Cancer Metastatic,Colorectal Cancer Metastatic,Pancreatic Neoplasms,Neoplasms

PROVIDER: 2364813 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR